---
title: 2022 IRIS® Registry Report | Verana Health
image: https://info.veranahealth.com/hubfs/IRIS%20Report%202022.png
---

[![Verana Health](https://info.veranahealth.com/hs-fs/hubfs/VeranaHealth_Logo.png?width=1464&height=210&name=VeranaHealth_Logo.png "Verana Health")](https://www.veranahealth.com/)

## 2022 IRIS® Registry Report

## ![2022_IRIS®_Registry_Report_1](https://info.veranahealth.com/hs-fs/hubfs/2022_IRIS%C2%AE_Registry_Report_1.png?width=326&height=422&name=2022_IRIS%C2%AE_Registry_Report_1.png)The IRIS® Registry (Intelligent Research in Sight) is the nation’s first and world’s largest electronic health record-based comprehensive eye disease and condition registry.

## In this year's report, we highlight 15 studies that were published in 2022 using IRIS Registry data, we take a closer look at clinic patient volumes as we enter post-COVID clinical care, brand-level market tracking of anti-VEGF agents, and Qdata GA, a curated data set that will spur research in the rapidly developing area of geographic atrophy.

## Fill out the form to request a copy of the 2022 IRIS® Registry Report.

## Request a Copy

![Dots Divider](https://info.veranahealth.com/hubfs/Dots/Dots%20Divider.png "Dots Divider")

© 2026 Verana Health All rights reserved.

[Privacy Policy](https://www.veranahealth.com/privacy-policy)